Literature DB >> 29311346

Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Diabetes Mellitus and Chronic Kidney Disease: Turning the Page.

Jorge Plutzky1, George Bakris2.   

Abstract

Entities:  

Keywords:  Editorials; cardiovascular diseases; diabetes mellitus; kidney diseases

Mesh：

Substances：

Year:  2018        PMID： 29311346     DOI： 10.1161/CIRCULATIONAHA.117.031422

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

1.  Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.

Authors:  Brendon L Neuen; Toshiaki Ohkuma; Bruce Neal; David R Matthews; Dick de Zeeuw; Kenneth W Mahaffey; Greg Fulcher; Mehul Desai; Qiang Li; Hsiaowei Deng; Norm Rosenthal; Meg J Jardine; George Bakris; Vlado Perkovic
Journal:  Circulation       Date:  2018-10-09       Impact factor: 29.690

2.  Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia.

Authors:  Shilpa Vijayakumar; Javed Butler; George L Bakris
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.